MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/cix016

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017

Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.

Herrick Jesica A, Legrand Fanny, Gounoue Raceline, Nchinda Godwin, Montavon Céline, Bopda Jean, Tchana Steve Mbickmen, Ondigui Bienvenu Etogo, Nguluwe Konrad, Fay Michael P, Makiya Michelle, Metenou Simon, Nutman Thomas B, Kamgno Joseph, Klion Amy D

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Severe adverse reactions have been observed in individuals with Loa loa infection treated with either diethylcarbamazine (DEC), the drug of choice for loiasis, or ivermectin (IVM), which is used in mass drug administration programs for control of onchocerciasis and lymphatic filariasis in Africa. In this study, posttreatment clinical and immunologic reactions were compared following single-dose therapy with DEC or IVM to assess whether these reactions have the same underlying pathophysiology.

METHODS

Twelve patients with loiasis and microfilarial counts <2000 mf/mL were randomized to receive single-dose DEC (8 mg/kg) or IVM (200 µg/kg). Clinical and laboratory assessments were performed at 4, 8, 24, 48, and 72 hours and 5, 7, 9, and 14 days posttreatment.

RESULTS

Posttreatment adverse events were similar following DEC or IVM, but peaked earlier in subjects who received DEC, consistent with a trend toward more rapid and complete microfilarial clearance in the DEC group. After a transient rise (post-IVM) or fall (post-DEC) in the first 24 hours posttreatment, the eosinophil count rose significantly in both groups, peaking at day 5 in the DEC group and day 9 in the IVM group. Serum interleukin 5 levels and eosinophil activation, as assessed by surface expression of CD69 and serum levels of eosinophil granule proteins, were increased posttreatment in both groups.

CONCLUSIONS

Despite differences in eosinophil and lymphocyte counts during the first 24 hours posttreatment, the overall pattern of hematologic and immunologic changes suggest that posttreatment reactions following DEC and IVM share a common pathophysiology.

CLINICAL TRIALS REGISTRATION: NCT01593722.

Для цитирования: Herrick Jesica A, Legrand Fanny, Gounoue Raceline, Nchinda Godwin, Montavon Céline, Bopda Jean, Tchana Steve Mbickmen, Ondigui Bienvenu Etogo, Nguluwe Konrad, Fay Michael P, Makiya Michelle, Metenou Simon, Nutman Thomas B, Kamgno Joseph, Klion Amy D. Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017. DOI: 10.1093/cid/cix016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.